Effect of anti-epileptic drugs on first trimester screening test results.

[1]  N. Delanty,et al.  Changing antiepilepsy drug-prescribing trends in women with epilepsy in the UK and Ireland and the impact on major congenital malformations , 2018, Journal of Neurology, Neurosurgery, and Psychiatry.

[2]  Berna Tari Kasnakoglu,et al.  Economic analysis of prenatal screening strategies for Down syndrome in singleton pregnancies in Turkey. , 2017, European journal of obstetrics, gynecology, and reproductive biology.

[3]  P. Pennell,et al.  Delivery of a Personalized Treatment Approach to Women with Epilepsy , 2017, Seminars in Neurology.

[4]  U. Kayisli,et al.  hCG: Biological Functions and Clinical Applications , 2017, International journal of molecular sciences.

[5]  K. Dağlar,et al.  Influence of Behçet's disease on first and second trimester serum screening markers , 2017, The journal of obstetrics and gynaecology research.

[6]  P. Pennell.  Use of Antiepileptic Drugs During Pregnancy: Evolving Concepts , 2016, Neurotherapeutics.

[7]  U. Dilmen,et al.  First and second trimester biochemical markers in familial mediterranean fever. , 2013, European review for medical and pharmacological sciences.

[8]  T. Tomson,et al.  Antiepileptic drug treatment in pregnancy: Changes in drug disposition and their clinical implications , 2013, Epilepsia.

[9]  K. Patrycja,et al.  Effects of valproic acid (VPA) and levetiracetam (LEV) on proliferation, apoptosis and hormone secretion of the human choriocarcinoma BeWo cell line. , 2011 .

[10]  A. Donnenfeld,et al.  Moderately Increased Risks of Down's Syndrome (1/51–1/270) Identified on First Trimester Sequential Screening: What do Patients do with this Information? , 2010, Journal of medical screening.

[11]  G. Take,et al.  Histologic and morphologic effects of valproic acid and oxcarbazepine on rat uterine and ovarian cells , 2010, Epilepsia.

[12]  N. Gilhus,et al.  Complications during pregnancy in women with epilepsy: population‐based cohort study , 2009, BJOG : an international journal of obstetrics and gynaecology.

[13]  T. Milewicz,et al.  Effects of levetiracetam and valproate on reproductive endocrine function studied in human ovarian follicular cells , 2009, Epilepsia.

[14]  H. Chiou,et al.  Affect of seizures during gestation on pregnancy outcomes in women with epilepsy. , 2009, Archives of neurology.

[15]  L. Kiesel,et al.  Influence of maternal systemic lupus erythematosus on first‐trimester combined screening for chromosomal abnormalities , 2007, Prenatal diagnosis.

[16]  C. Harden,et al.  Optimizing therapy of seizures in women who use oral contraceptives , 2006, Neurology.

[17]  P. Kaplan,et al.  Risks and management of pregnancy in women with epilepsy. , 2004, Cleveland Clinic journal of medicine.

[18]  C. Rao,et al.  The central role of human chorionic gonadotropin in the formation of human placental syncytium. , 2003, Endocrinology.

[19]  S. Cicero,et al.  Increased fetal nuchal translucency at 11–14 weeks , 2002, Prenatal diagnosis.

[20]  H. Cuckle,et al.  Maternal serum human chorionic gonadotrophin levels in systemic lupus erythematosus and antiphospholipid syndrome , 2001, Prenatal diagnosis.

[21]  W. Robertson,et al.  Gonadotrophin heterogeneity and biopotency: implications for assisted reproduction. , 1998, Molecular human reproduction.

[22]  K. Nicolaides,et al.  Maternal Serum Pregnancy-Associated Plasma Protein a and Fetal Nuchal Translucency Thickness for the Prediction of Fetal Trisomies in Early Pregnancy , 1994, Obstetrics and gynecology.